Gonadotropin-releasing hormone agonist protects ovarian function in young patients with ovarian malignancy undergoing platinum-based chemotherapy: A prospective study

PURPOSE: We aimed to ascertain the effectiveness of gonadotropin-releasing hormone (GnRH) agonist co-therapy for the preservation of ovarian function in patients with ovarian malignancy who underwent unilateral salpingo-oophorectomy and platinum-based chemotherapy. METHODS: We enrolled 158 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Ya, Duan, Haoran, Wang, Dong, Li, Huiqing, Jia, Jia, Zhang, Jialin, Li, Linlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627175/
https://www.ncbi.nlm.nih.gov/pubmed/36338740
http://dx.doi.org/10.3389/fonc.2022.986208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627175/
https://www.ncbi.nlm.nih.gov/pubmed/36338740
http://dx.doi.org/10.3389/fonc.2022.986208

Ejemplares similares